(Q34067007)

30 July 2017

1 reference

title

New insights into genetic aspects of Alzheimer's disease. Does genetic information make a difference in clinical practice? (English)

1 reference

30 July 2017

0 references

D Blacker

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

published in

Postgraduate Medicine

1 reference

30 July 2017

volume

108

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

119-22, 125-6, 129

1 reference

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

The gene defects responsible for familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

The genetics of Alzheimer disease: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Apolipoprotein E and cognitive change in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Evaluation and use of diagnostic tests in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.10.1267

21 January 2018

Identifiers

DOI

10.3810/PGM.2000.10.1267

1 reference

30 July 2017

1 reference